Moderna's CMV trial offers further upside - UBS

Go back to Moderna's CMV trial offers further upside - UBS
Marina Biotech, Inc. (NASDAQ: MRNA) Delayed: 59.81 +0.64 (1.08%)
Previous Close $59.17    52 Week High $0.52 
Open $59.75    52 Week Low $0.08 
Day High $60.77    P/E N/A 
Day Low $58.41    EPS $-3.80 
Volume 6,238,810